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Purpose: Laparoscopic colectomy has clinical benefits such as short hospital stay, 
less postoperative pain, and early return of bowel function. However, objective ev-
idence of its immunologic and oncologic benefits is scarce. We compared func-
tional recovery after open versus laparoscopic sigmoidectomy and investigated the 
effect of open versus laparoscopic surgery on acute inflammation as well as tumor 
stimulation. Materials and Methods: A total of 57 patients who were diagnosed 
with sigmoid colon cancer were randomized for elective conventional or laparo-
scopically assisted sigmoidectomy. Serum samples were obtained preoperatively 
and on postoperative day 1. C-reactive protein (CRP) and interleukin-6 (IL-6) were 
measured as inflammation markers, and vascular endothelial growth factor (VEGF) 
and insulin-like growth factor binding protein-3 (IGFBP-3) were used as tumor stim-
ulation factors. Clinical parameters and serum markers were compared. Results: 
Postoperative hospital stay (p=0.031), the first day of gas out (p=0.016), and the 
first day of soft diet (p<0.001) were significantly shorter for the laparoscopic sur-
gery group than the open surgery group. The levels of CRP, IL-6, and VEGF rose 
significantly, and the concentration of IGFBP-3 fell significantly after both open 
and laparoscopic surgery. However, there were no significant differences in the pre-
operative and postoperative levels of CRP, IL-6, VEGF, and IGFBP-3 between the 
two groups. Conclusion: Our data suggest that both open and laparoscopic surger-
ies are accompanied by significant changes in IL-6, CRP, IGFBP-3, and VEGF 
levels. Acute inflammation markers and tumor stimulating factors may not reflect 
clinical benefits of laparoscopic surgery.
Key Words:   Colon neoplasm, laparoscopic surgery, acute inflammation, tumor 
stimulation
INTRODUCTION
Since the first report of a laparoscopic colectomy by Jacobs, et al.1 in 1991, several 
prospective studies have reported that laparoscopic surgery was similar to conven-
tional open surgery in terms of oncologic safety.2-4 Moreover, laparoscopic colec-
tomy has benefits like shorter hospital stay, less postoperative pain, and early re-
turn of bowel function.5 These favorable early outcomes of laparoscopic colectomy 
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roscopic surgery on acute inflammation as well as tumor 
stimulation. In addition, the relationship between the postop-
erative elevation of IL-6 and changes of VEGF and IGFBP-3 
was examined, on the proposition that this alteration might 
have effect on the tumor growth.
MATERIALS AND METHODS
　　　
Patients
We included 81 patients who were diagnosed of having re-
sectable sigmoid colon cancer from October 2008 to June 
2009. Patients were randomized for elective conventional or 
laparoscopically assisted sigmoidectomy using random num-
bers. Preoperative evaluations consisted of history taking, 
physical examination, carcinoembryonic antigen (CEA) lev-
el, peripheral blood test, colonoscopy, and computed tomog-
raphy. Exclusion criteria were as follows: distant metastasis, 
blood transfusion, immunosuppressant medication, and his-
tory of chemotherapy or radiotherapy treatment. Informed 
consent was obtained from each patient. This study was ap-
proved by the Institutional Review Board.
Anesthesia and surgical procedure
All patients were treated with premedication and had standard 
anesthesia. The operations were performed by experienced 
surgeon (NK Kim) in both open and laparoscopically assisted 
technique. All open surgeries were performed through a mid-
line skin incision. After mobilizing the mesocolon, the infe-
rior mesenteric artery and vein were doubly ligated and di-
vided. Anastomosis was accomplished using a circular 
stapler after sigmoidectomy.
In the laparoscopically assisted sigmoidectomy, patient’s 
position of operating room was a modified lithotomy with 
right side and head down. An initial 12-mm camera port 
was inserted using the open technique, and pneumoperito-
neum was accomplished with carbon dioxide. Two 5-mm 
ports were introduced into the upper right and left abdomi-
nal quadrants and two more 12-mm ports were inserted in 
the lower right and left abdominal quadrants under laparo-
scopic visual guidance. After mobilizing the mesocolon, the 
inferior mesenteric artery and vein were ligated with lapa-
roscopic clips and divided with laparoscopic scissors. The 
specimen was extracted from mini-laparotomy incision in 
the left lower abdominal quadrant after transection of distal 
bowel and extracorporeal preparation for end-to-end anas-
tomosis was completed after proximal bowel resection. In-
have been shown in a number of studies.6-8 As a result, lapa-
roscopic colectomy has been widely accepted for resectable 
carcinoma. However, these early outcomes of laparoscopic 
surgery are based on clinical observations. Some investiga-
tors have compared patterns of postoperative cytokine and 
stress responses with laparoscopically assisted colectomy to 
conventional open colectomy.9-14 C-reactive protein (CRP), 
interleukin (IL)-1, IL-6, and tumor necrosis factor-α (TNF-α) 
have been used as major acute-phase response mediators.15 
However, results of these studies have been proved inconsis-
tent. This inconsistency has been attributed to inhomogenous 
operation type, different sampling timing, and enrollment of 
immunocompromized patients. Therefore, the impact of lap-
aroscopic colectomy for carcinoma on acute inflammation 
has not yet been established.
Recently, Belizon, et al.16 reported that vascular endothe-
lial growth factor (VEGF) which is an important inducer of 
angiogenesis was significantly higher in open surgery than 
in laparoscopic surgery. Angiogenesis plays a critical role in 
the growth and development of tumor.17 Therefore, a high 
level of VEGF may influence the growth of tumor.18 It is 
possible that open surgery stimulates residual tumor cells 
more than laparoscopic surgery does.
Another tumor stimulation factor whose level changes 
after surgery and may consequently impact tumor growth is 
insulin-like growth factor binding protein-3 (IGFBP-3). Ma-
trix metalloproteinase 9 (MMP-9) and tissue inhibitor of me-
talloproteinase (TIMP-1) may also impact tumor growth.19 
Kirman, et al.20 demonstrated that postoperative plasma 
with a low level of IGFBP-3 withdrawn from patients who 
had undergone major operation stimulated tumor growth in 
vitro compared with preoperative plasma. This postopera-
tive reduction of IGFBP-3 was shown to be more dramatic 
in open surgery than in laparoscopic surgery.21 Although it 
is not clinically proven that a high level of VEGF and a low 
level of IGFBP-3 may have an impact on tumor growth, 
open surgery has stronger association with tumor stimulation 
factors than in laparoscopic surgery does. Interestingly, in-
flammatory cytokines, including IL-6, have been reported to 
be associated with tumor stimulating factors such as VEGF 
and IGFBP-3.22,23
However, few studies have compared both acute inflam-
mation and tumor stimulating factors in homogenous group 
of patients who were undergoing open and laparoscopic 
surgery. In the current study, we compared functional re-
covery after open versus laparoscopic surgery for sigmoid 
colon cancer, and investigated the effect of open versus lapa-
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Windows (SPSS Inc., Chicago, IL, USA). Mann-Whitney 
test for continuous variables and Fisher’s exact tests for cat-
egorical variables were used for statistical comparison of 
clinical characteristics. Difference within each group was 
tested with the Wilcoxon matched pairs test. A Spearman 
correlation coefficient was determined to correlate changes 
in VEGF and IGFBP-3 levels with postoperative IL-6 levels, 
respectively. A value of p<0.05 was considered significant.
RESULTS
 
A total of 81 patients were recruited in this study. Nine pa-
tients with immunosuppressant medication, distant metasta-
sis, and transfusion were excluded. Two patients had anas-
tomotic leakage, and one patient had tumor perforation at 
the time of surgery. Twelve patients were excluded because 
their samples were found to be inappropriate for ELISA test 
during the collection process. As a result, we enrolled 57 pa-
tients in the study. A flow chart of patient selection is de-
scribed in Fig. 1. Nineteen patients received open surgery, 
and 38 patients received laparoscopic surgery. The two 
groups were comparable in terms of age, gender, body mass 
index, preoperative peripheral neutrophil count, preopera-
tive CEA level, preoperative morbidity, and the American 
Society of Anesthesiologists score. However, the mean op-
eration time was significantly longer in the laparosopic sur-
gery group, whereas postoperative hospital stay, the first 
day of gas out, and the first day of soft diet were significantly 
shorter and earlier in the laparoscopic surgery group com-
pared to the open surgery group. A summary of patient char-
acteristics comparing open and laparoscopic surgeries is 
shown in Table 1.
No differences in serum concentrations of preoperative 
tracorporeal anastomosis was achieved using a circular sta-
pler and the wound was closed with absorbable sutures. In 
both surgical techniques, a Jackson-Pratt drain was placed 
in the pelvis for drainage.
Postoperative treatment and data collection
After both open and laparoscopic surgeries, a clear liquid 
diet was started one day after patients passed flatus. Patients 
were given 1 mg/kg of pethidine every six hours until the 
first postoperative day (POD1) or upon their request after 
surgery. Patients were discharged if following discharge cri-
teria were met: 1) passing stool, 2) tolerating soft diet, 3) be-
ing comfortable on oral analgesia, 4) white blood cell count 
within the normal range, and 5) being happy to be discharged 
with full ambulation.
After surgery, we collected their clinical data, including 
operation time, amount of transfusion, time of the first pass-
ing flatus, time when soft diet began, duration of postopera-
tive hospital stay, complications, and pathologic report.  
Blood sampling and processing
Blood was taken before surgery and the POD1. Seven milli-
liters of blood was withdrawn from all patients by peripheral 
venipuncture. The specimens were centrifuged within four 
hours after withdrawal. The serum was collected and stored 
at -70°C until enzyme-linked immunosorbent assay (ELI-
SA) was performed. CRP and IL-6 were measured as in-
flammation markers, and VEGF and IGFBP-3 were used as 
tumor stimulation factors. CRP, IL-6, VEGF, and IGFBP-3 
level were determined in duplicate using ELISA test (Milli-
pore, Billerica, MA, USA for CRP; BD Biosciences, San 
Jose, CA, USA for IL-6; RayBiotech, Inc., Norcross, GA, 
USA for IGFBP-3 and VEGF). The results of ELISA were 
read using an automated microplate reader (SpectraMax 
Plus384, Sunnyvale, CA, USA) and calculated with software 
program (SoftMax Pro, Sunnyvale, CA, USA).
Statistical analysis
On the basis of our institute’s data base over the last five 
years, the mean difference of hospital stay between open 
and laparoscopically assisted sigmoidectomies was 4.53 
days. Assuming a pooled standard deviation of 4.8 days, 
and assigning α=0.05, β=0.15, 10% of dropout rate, and 1 : 2 
allocation, at least 57 patients were needed. We decided to 
apply 1 : 2 allocation of recruits because patients preferred 
to receive laparoscopic surgery. 
Statistical analysis was carried out using SPSS 12.0 for Fig. 1. The flow chart of patient selection process.
Analyzed (n=19) Analyzed (n=38)
Inappropriate samples (n=2)
Randomization
Enrollment (n=81)
Open surgery (n=27)
Excluded due to immunosup-
  pressant (n=3)
Distant metastasis (n=2)
Blood transfusion (n=1)
Laparoscopic surgery (n=54)
Excluded due to anastomotic 
  leakage (n=2)
Distant metastasis (n=3)
Tumor perforation (n=1)
Inappropriate samples (n=10)
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differences in CRP, IL-6, VEGF, and IGFBP-3 levels be-
tween the open and laparoscopic surgery groups.
There was a significant correlation between the POD1 
IL-6 level and a drop in VEGF which was calculated as a 
ratio between POD1/preoperative VEGF (r=0.293; p=0.027) 
(Fig. 6). In addition, a drop in IGFBP-3 calculated as a ratio 
between preoperative/POD1 IGFBP-3 also had significant 
correlation with POD1 IL-6 (r=0.354; p=0.007) (Fig. 7).
and postoperative CRP, IL-6, IGFBP-3, and VEGF were 
observed between the two groups (Table 2). However, CRP, 
IL-6, and VEGF levels rose significantly after both open and 
laparoscopic surgeries (p<0.001 in each group) (Figs. 2, 3 
and 4). In contrast, the concentration of IGFBP-3 decreased 
significantly after open and laparoscopic surgeries (p=0.03 
in the open surgery group and p=0.003 for the laparoscopic 
surgery group) (Fig. 5). However, there were no significant 
Table 2. Inflammatory and Tumor Stimulating Factors between Open and Laparoscopic Surgery
OS (n=19) LS (n=38) p value
Preoperative CRP (ng/mL, median & range)        9.4 (5.2-13.1)        9.3 (3.7-14.5) 0.260
Postoperative CRP (ng/mL, median & range)      17.8 (9.6-80.1)      16.9 (9.4-21.8) 0.229
Preoperative IL-6 (pg/mL, median & range)      12.4 (0.5-81.6)        6.5 (0.1-360.3) 0.176
Postoperative IL-6 (pg/mL, median & range)    119.5 (1.78-298.7)      49.2 (2.3-407.7) 0.407
Preoperative VEGF (pg/mL, median & range) 1,462.9 (91.6-2240.7) 1,070.4 (19.2-4949.1) 0.243
Postoperative VEGF (pg/mL, median & range) 2,284.7 (922.7-6752.1) 2,078.8 (311.0-8275.5) 0.388
Preoperative IGFBP-3 (ng/mL, median & range)      20.6 (16.9-22.6)      20.4 (13.7-24.0) 0.761
Postoperative IGFBP-3 (ng/mL, median & range)      17.5 (13.4-22.5)      18.3 (9.7-23.4) 0.919
OS, open surgery; LS, laparoscopic surgery; CRP, C-reactive protein; IL-6, interleukin-6; VEGF, vascular endothelial growth factor; IGFBP-3, 
insulin-like growth factor binding protein-3.
Table 1. Clinical Characteristics
OS LS
p value
n=19 (%) n=38 (%)
Age (yrs) 1.000
    ≤60   7 (36.8) 14 (36.8)
    >60 12 (63.2) 24 (63.2)
Gender 0.775
    Male 13 (68.4) 24 (63.2)
    Female   6 (31.6) 14 (36.8)
CEA level (ng/mL) 0.541
    ≤5 12 (63.2) 28 (73.7)
    >5   7 (36.8) 10 (26.3)
Comorbidity 1.000
    No 10 (52.6) 20 (52.6)
    Yes   9 (47.4) 18 (47.4)
ASA 0.763
    1 14 (73.7) 25 (65.8)
    2   5 (26.3) 13 (34.2)
Mean BMI (kg/m2) 23.1±3.3 23.6±2.8 0.537
Mean operation time (min) 199.6±74.0 222.7±45.6 0.011
Mean preoperative neutrophil count (103/mL)   5.7±3.1   4.5±1.5 0.257
Mean postoperative neutrophil count (103/mL)   9.8±3.1 10.5±3.1 0.446
Mean postoperative hospital stay (day) 12.5±4.7 10.2±3.4 0.031
First day of gas out (day)   3.6±2.5   2.5±1.0 0.016
First day of soft diet (day)   6.7±2.5   4.9±1.8 <0.001
Stage 0.159
    II   6 (31.6) 21 (55.3)
    III 13 (68.4) 17 (44.7)
OS, open surgery; LS, laparoscopic surgery; CEA, carcinoembryonic antigen; BMI, body mass index; ASA, American Society of Anesthe-
siologists.
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been shown to have oncologic outcomes similar to those of 
open colectomy.2-4 Laparoscopic surgery is also known to 
be associated with short hospital stay, less postoperative pain, 
and early resumption of normal diet.5 This favorable early 
DISCUSSION
In several prospective studies, laparoscopic colectomy has 
Fig. 2. Changes in the serum concentration of C-reactive protein 
(CRP) in patients undergoing open or laparoscopic surgery for sig-
moid colon cancer. No significant differences were found between 
the open and laparoscopic surgery groups. *p<0.001 Preoperative 
(Preop) value versus the first postoperative day (POD1).
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Fig. 4. Changes in the serum concentration of vascular endothelial 
growth factor (VEGF) in patients undergoing open or laparoscopic 
surgery for sigmoid colon cancer. No significant differences were 
found between the open and laparoscopic surgery groups. *p<0.001 
Preoperative (Preop) value versus the first postoperative day (POD1).
Fig. 6. A postoperative increase of vascular endothelial growth fac-
tor (VEGF) correlates with a concentration of the first postoperative 
day (POD1) interleukin-6 (r=0.293, p=0.027). The ratio between the 
values of the POD1 versus preoperative (Preop) VEGF was used to 
analyze for a postoperative increase of concentration.
Fig. 7. A postoperative decrease of insulin-like growth factor bind-
ing protein-3 (IGFBP-3) correlated with a concentration of the first 
postoperative day (POD1) interleukin-6 (r=0.354, p=0.007). The ratio 
between the values of preoperative (Preop) versus the POD1 
IGFBP-3 was used to analyze for a postoperative loss of the protein.
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Fig. 3. Changes in the serum concentration of interleukin-6 (IL-6) 
in patients undergoing open or laparoscopic surgery for sigmoid 
colon cancer. No significant differences were found between the 
open and laparoscopic surgery groups. *p<0.001 Preoperative 
(Preop) value versus the first postoperative day (POD1).
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Fig. 5. Changes in the serum concentration of insulin-like growth 
factor binding protein-3 (IGFBP-3) in patients undergoing open or 
laparoscopic surgery for sigmoid colon cancer. No significant dif-
ferences were found between the open and laparoscopic surgery 
groups. *p=0.03 Preoperative (Preop) value versus the first post-
operative day (POD1). †p=0.003 Preoperative (Preop) value versus 
the first postoperative day (POD1).
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surgery may vary greatly because of surgical technique and 
patient selection. Technique of laparoscopic surgery is influ-
enced by surgeon’s experience, patient factor, and tumor 
factor. In contrast, open surgery is well established and give 
similar results. According to our data, the level of postoper-
ative IL-6 level was more variable in the laparoscopic than 
in the surgery group. There was a problem in the current 
study that deserves to be mentioned. Time interval from the 
end of surgery and sampling time of the first postoperative 
day varied in each patient. Therefore, our study was limited 
by the bias inherent to quantitative analysis of this nature.
The early outcomes of the laparoscopic surgery group 
were remarkable. There were significant differences in op-
eration time, postoperative hospital stay, and return of bow-
el function between open and laparoscopic surgery groups. 
Clinical outcomes after laparoscopic surgery were better 
than after open surgery, although laparoscopic surgery 
group needed longer operation time.
A recent study evaluated plasma VEGF levels preopera-
tively and on days 1 and 3 after open and laparoscopic colorec-
tal resections for benign and malignant diseases as well as 
after gastric bypass for morbid obesity.16 This study demon-
strated that the mean values of VEGF significantly increased 
on POD 1 and 3 after colorectal resection and gastric bypass, 
and that the extent of elevation at postoperative time was 
significantly greater for the open surgery group. An elevated 
VEGF level may remain unchanged for approximately three 
weeks after curative surgery.18
A high level of VEGF may stimulate the development 
and growth of metastases.27 Major surgery has been associ-
ated with IGFBP-3 depletion and increased plasma MMP-9 
levels, which are related with tumor stimulation.19,20 In our 
study, the VEGF level increased and the IGFBP-3 level de-
creased significantly after both open and laparoscopic sig-
moidectomies (p<0.001 for VEGF in both open and laparo-
scopic surgery; p=0.03 for IGFBP-3 in open surgery, p=0.003 
for IGFBP-3 in laparoscopic surgery) (Figs. 4 and 5). How-
ever, there were no significant differences in the postopera-
tive VEGF and IGFBP-3 levels between the open and lapa-
roscopic surgery groups. Do increased VEGF and decreased 
IGFBP-3 levels after both open and laparoscopic surgeries 
affect tumor growth? Should clinicians start anti-tumor che-
motherapy in early postoperative time? However, it is not 
clear whether such therapy would be safe or effective in 
early time of post-operation. Moreover, plasma VEGF lev-
els did not increase in all patients after surgery and varied 
broadly from patient to patient.18 Therefore, clinical impor-
outcome has been regarded to be related to reduced bowel 
injury, surgical metabolic stress, and immunosuppressive re-
sponse.24 CRP is a key marker of acute-phase proteins as its 
level increases in proportion to the degree of inflammation. 
Plasma concentration of CRP serves as a reliable screening 
test for acute-phase response. The CRP level usually rises 4 
to 12 hours after surgery and peak at 24 hours. An elevated 
CRP level may remain for approximately two weeks.25 The 
acute-phase response consists of a series of hormonal, met-
abolic, and immunologic changes in response to surgery, 
trauma, or sepsis.26 TNF-α, IL-1β, and IL-6 are major com-
ponents of the acute-phase response in humans. Among these 
mediators, IL-6 is primarily responsible for the hepatic com-
ponent of the response, resulting in the synthesis of acute-
phase proteins. IL-6 usually peaks at 4 to 48 hours after sur-
gery and rapidly falls afterward. The levels of the cytokines 
and CRP have been identified to correspond with the severity 
of surgery and the presence of complications. Thus, these 
markers have been used to reflect surgical tissue trauma.26
Previous studies on acute-phase response after laparo-
scopic colorectal surgery have been inconclusive.9-14 Leung, 
et al.9 and Delgado, et al.14 demonstrated that an acute-phase 
response was less in the laparoscopic surgery group than in 
the open surgery group. Therefore, they suggested that the 
difference in the systemic cytokine response may affect an-
ti-inflammation and immunosuppression. In contrast, how-
ever, Tang, et al.10 Fukushima, et al.12 and Dunker, et al.13 
described no differences in the acute-phase response in pa-
tients receiving conventional open surgery and those who 
had laparoscopic surgery for colorectal cancer. Interesting-
ly, Stage, et al.11 showed that CRP and IL-6 peak levels were 
higher in the laparoscopic than in the open group. These 
studies were relatively uniform and conducted with ran-
domized fashion. However, some of these studies included 
metastatic disease, immunocompromized patients, and in-
constant surgical procedure. In the present study, we used a 
homogenous group of patients with sigmoid colon cancer, 
and excluded patients with metastatic disease, use of immu-
nosuppressant, and intraoperative transfusion.
In our study, CRP and IL-6 levels increased significantly 
after both open and laparoscopic sigmoidectomy (p<0.001) 
(Figs. 2 and 3), indicating significant activation of inflam-
matory response. There were no significant differences in the 
postoperative CRP and IL-6 levels between the open and lap-
aroscopic surgery groups. This phenomenon could be ex-
plained by surgical bowel injury, which was comparable in 
both surgical techniques. The IL-6 level after laparoscopic 
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tance of these findings remains largely unclear.
In the present study, we demonstrated that a rise in the 
VEGF concentration and reduction in the IGFBP-3 concen-
tration after surgery were associated with the postoperative 
IL-6 level. Similarly, Kirman, et al.23 showed that the IL-6 
level on POD1 was found to be significantly correlated with 
a decrease in plasma IGFBP-3 after open surgery (r=0.81, 
p<0.001). However, it is not known how exactly IL-6 affects 
VEGF and IGFBP-3 balance. Several investigators have re-
ported that IL-6 induced gene expression of various protease 
such as cathepsins and metalloproteinase-13, and enhanced 
IGFBP-3 proteolysis.28-30 Moreover, IL-6 has been found to 
upregulate VEGF expression using various molecular path-
ways.22 However, our results suggest that an acute inflamma-
tory response may be correlated with VEGF and IGFBP-3 
which are associated with tumor stimulation. Knowledge 
on the inflammatory response-mediated pathway of VEGF 
production and IGFBP-3 depletion may result in novel thera-
peutic strategies for colon cancer patients undergoing sur-
gery. The relationship of inflammation and tumor stimula-
tion after surgery should be taken into consideration and 
requires further evaluation in the future.
In conclusion, we demonstrated herein that early outcome 
after laparoscopic surgery was better than that after open sur-
gery despite longer operation time. Thus, laparoscopic sig-
moidectomy is an acceptable and safe procedure for sigmoid 
colon cancer. This study did not find any difference in preop-
erative and postoperative CRP, IL-6, VEGF, and IGFBP-3 
levels between the open and laparoscopic surgery groups. 
However, the levels of these markers were significantly 
changed after both open and laparoscopic surgeries. Postop-
erative increase of the VEGF level and decrease of IGFBP-3 
level were correlated with the postoperative IL-6 level. In-
flammation markers and tumor stimulating factors may not 
reflect clinical benefit of laparoscopic surgery.
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